Slow Capital, Inc. Kezar Life Sciences, Inc. Transaction History

Slow Capital, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$7.99 - $10.75 $1.2 Million - $1.62 Million	150,663 New	150,663 $1.3 Million
Q2 2022 Jul 28, 2022	SELL	$4.58 - $17.13 $690,036 - $2.58 Million	-150,663 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$12.3 - $18.33 $872,832 - $1.3 Million	-70,962 Reduced 32.02%	150,663 $2.5 Million
Q1 2021 May 05, 2021	BUY	$5.24 - $6.99 $1.16 Million - $1.55 Million	221,625 New	221,625 $1.32 Million
Q2 2019 Aug 01, 2019	SELL	$7.09 - $21.9 $1.46 Million - $4.5 Million	-205,544 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$16.83 - $23.75 $3.31 Million - $4.66 Million	196,406 Added 2149.33%	205,544 $3.65 Million
Q4 2018 Jan 30, 2019	BUY	$20.21 - $32.9 $184,678 - $300,640	9,138 New	9,138 $216,000

1.54M

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $438M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Slow Capital, Inc. with notifications on news.